160 related articles for article (PubMed ID: 25072501)
1. Approach and management of patients with chronic hepatitis B and C during the course of inflammatory bowel disease.
Coban S; Kekilli M; Köklü S
Inflamm Bowel Dis; 2014 Nov; 20(11):2142-50. PubMed ID: 25072501
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus and inflammatory bowel disease.
Horn TL; Reynolds J; de Villiers W; Peña LR
Dig Dis Sci; 2009 Jun; 54(6):1171-7. PubMed ID: 18975088
[TBL] [Abstract][Full Text] [Related]
3. Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection.
Degasperi E; Caprioli F; El Sherif O; Back D; Colombo M; Aghemo A
Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1373-1383. PubMed ID: 27718758
[TBL] [Abstract][Full Text] [Related]
4. Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection.
Morisco F; Castiglione F; Rispo A; Stroffolini T; Sansone S; Vitale R; Guarino M; Biancone L; Caruso A; D'Inca R; Marmo R; Orlando A; Riegler G; Donnarumma L; Camera S; Zorzi F; Renna S; Bove V; Tontini G; Vecchi M; Caporaso N
J Viral Hepat; 2013 Mar; 20(3):200-8. PubMed ID: 23383659
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease.
Morisco F; Castiglione F; Rispo A; Stroffolini T; Vitale R; Sansone S; Granata R; Orlando A; Marmo R; Riegler G; Vecchi M; Biancone L; Caporaso N
Dig Liver Dis; 2011 Jan; 43 Suppl 1():S40-8. PubMed ID: 21195371
[TBL] [Abstract][Full Text] [Related]
6. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
Bonifati C; Lora V; Graceffa D; Nosotti L
World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease.
Sansone S; Guarino M; Castiglione F; Rispo A; Auriemma F; Loperto I; Rea M; Caporaso N; Morisco F
World J Gastroenterol; 2014 Apr; 20(13):3516-24. PubMed ID: 24707134
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease and hepatitis B and C.
Chevaux JB; Bigard MA; Bensenane M; Oussalah A; Jarlot S; Belle A; Nani A; Bronowicki JP; Peyrin-Biroulet L
Gastroenterol Clin Biol; 2009 Dec; 33(12):1082-93. PubMed ID: 19896313
[TBL] [Abstract][Full Text] [Related]
9. [Protocol for the treatment of chronic viral hepatitis].
Dalmi L; Gervain J; Horváth G; Hunyady B; Ibrányi E; Makara M; Pár A; Szalay F; Tornai I; Telegdy L; ;
Orv Hetil; 2008 Jan; 149(3):129-35. PubMed ID: 18194921
[No Abstract] [Full Text] [Related]
10. Liver dysfunction in patients with IBD under immunosuppressive treatment: do we need to fear?
Beaugerie L; Gerbes AL
Gut; 2010 Oct; 59(10):1310-1. PubMed ID: 20833661
[No Abstract] [Full Text] [Related]
11. Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3).
Loras C; Gisbert JP; Saro MC; Piqueras M; Sánchez-Montes C; Barrio J; Ordás I; Montserrat A; Ferreiro R; Zabana Y; Chaparro M; Fernández-Bañares F; Esteve M;
J Crohns Colitis; 2014 Nov; 8(11):1529-38. PubMed ID: 25052345
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B and C Viruses and Biologics.
Grewal P; Sanghera R
Skin Therapy Lett; 2017 Jul; 22(4):7-9. PubMed ID: 28732153
[TBL] [Abstract][Full Text] [Related]
13. Current status of liver transplantation for hepatitis B virus.
Buchanan C; Tran TT
Clin Liver Dis; 2011 Nov; 15(4):753-64. PubMed ID: 22032527
[TBL] [Abstract][Full Text] [Related]
14. [Outcome of chronic hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive drugs and anti-TNF agents].
González-Artacho C; Rodríguez Sicilia MJ; Alegría-Motte C; Gómez García M
Gastroenterol Hepatol; 2014 Jan; 37(1):23-4. PubMed ID: 24094622
[No Abstract] [Full Text] [Related]
15. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.
Loras C; Gisbert JP; Mínguez M; Merino O; Bujanda L; Saro C; Domenech E; Barrio J; Andreu M; Ordás I; Vida L; Bastida G; González-Huix F; Piqueras M; Ginard D; Calvet X; Gutiérrez A; Abad A; Torres M; Panés J; Chaparro M; Pascual I; Rodriguez-Carballeira M; Fernández-Bañares F; Viver JM; Esteve M; ;
Gut; 2010 Oct; 59(10):1340-6. PubMed ID: 20577000
[TBL] [Abstract][Full Text] [Related]
16. Towards curative therapy of chronic viral hepatitis.
Bartenschlager R; Urban S; Protzer U
Z Gastroenterol; 2019 Jan; 57(1):61-73. PubMed ID: 30641605
[TBL] [Abstract][Full Text] [Related]
17. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
[TBL] [Abstract][Full Text] [Related]
18. Triple infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus: a clinical challenge.
Sterling RK
Am J Gastroenterol; 2003 Oct; 98(10):2130-4. PubMed ID: 14572556
[No Abstract] [Full Text] [Related]
19. Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents.
Juan J; Feld JJ
Curr Opin Rheumatol; 2014 Jul; 26(4):395-403. PubMed ID: 24841230
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline].
Horváth G; Hunyady B; Gervain J; Lengyel G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
Orv Hetil; 2014 Mar; 155 Suppl():25-36. PubMed ID: 24631887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
